
Lundbeck To Share Pipeline Data And Key Insights Into The Progression Of Rare Disease, Multiple System Atrophy, At ...
(MENAFN- PR Newswire) VALBY, Denmark, May 8, 2025 /PRNewswire/ -- H. Lundbeck A/S (Lundbeck) will present key pipeline data and patient perspectives from the phase II AMULET trial, investigating amlenetug as a potential new treatment option …